PFBT
RVMD icon

Parkside Financial Bank & Trust’s Revolution Medicines RVMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
94
+58
+161% +$8.47K ﹤0.01% 1435
2026
Q1 		$3.5K Buy
36
+18
+100% +$1.82K ﹤0.01% 1933
2025
Q4 		$1.43K Buy
18
+16
+800% +$1.05K ﹤0.01% 2216
2025
Q3 		$94 Sell
2
-32
-94% -$1.25K ﹤0.01% 2679
2025
Q2 		$1.25K Sell
34
-36
-51% -$1.38K ﹤0.01% 2171
2025
Q1 		$2.48K Buy
+70
New +$2.84K ﹤0.01% 1826

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Parkside Financial Bank & Trust's RVMD Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Revolution Medicines (RVMD) stake by 161% in Q2 2026, buying an estimated $8.47K and bringing the position to 94 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

Parkside Financial Bank & Trust first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Parkside Financial Bank & Trust held 94 shares of Revolution Medicines worth $17.6K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 58 Revolution Medicines shares in Q2 2026, an estimated $8.47K.
  • Revolution Medicines made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1435 holding.
  • Parkside Financial Bank & Trust first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.